|
GB767788A
(en)
|
1953-12-28 |
1957-02-06 |
Schering Corp |
Polyiodinated phenyl fatty acid compounds and process for their manufacture
|
|
US3211610A
(en)
*
|
1961-09-29 |
1965-10-12 |
Merck & Co Inc |
Benzoic acid ester derivatives for treating coccidiosis and method of using same
|
|
US3444232A
(en)
*
|
1966-05-18 |
1969-05-13 |
Squibb & Sons Inc |
O-alkyl or phenylalkyl benzohydroxamic acids
|
|
GB1359560A
(en)
|
1972-02-25 |
1974-07-10 |
Merck & Co Inc |
Preparation of pyrrylsalicylic acid
|
|
US4036951A
(en)
*
|
1973-03-12 |
1977-07-19 |
Synergistics, Inc. |
Ultra-violet filtration with certain aminosalicylic acid esters
|
|
FR2440353A1
(fr)
*
|
1978-11-03 |
1980-05-30 |
Science Union & Cie |
Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament
|
|
US4348223A
(en)
*
|
1980-12-05 |
1982-09-07 |
Ppg Industries, Inc. |
N-Alkyl-N-[3-(alkoxyalkyl)phenyl]-2-haloacetamide herbicides
|
|
DE3164618D1
(en)
*
|
1980-12-22 |
1984-08-09 |
Schering Ag |
3-substituted 2,4,6-trihalogenobenzamides and their salts, their preparation and their use as substitutes for natural sweetening agents, and sweeteners containing them
|
|
JPS58194814A
(ja)
|
1982-05-11 |
1983-11-12 |
Nippon Shinyaku Co Ltd |
免疫調節作用を有する薬剤
|
|
IL69282A
(en)
|
1982-09-02 |
1988-06-30 |
Euro Celtique Sa |
Method for the carboxylation of potassium phenoxide with carbon dioxide
|
|
DE3786452T2
(de)
*
|
1987-02-05 |
1993-10-21 |
Kureha Chemical Ind Co Ltd |
Benzylether-Verbindungen und Verfahren zu ihrer Herstellung.
|
|
AU1388388A
(en)
|
1987-04-01 |
1988-10-06 |
Dak-Laboratoriet A/S |
Benzoic acid derivatives and use thereof
|
|
EP0352826B1
(en)
|
1988-05-05 |
1994-10-26 |
Tillotts Pharma Ag |
Use of 5-aminosalicylic acid in the treatment of dermatological disorders
|
|
US5519014A
(en)
*
|
1990-10-22 |
1996-05-21 |
Borody; Thomas J. |
Treatment of non-inflammatory and non-infectious bowel disorders
|
|
DE69133348T3
(de)
|
1990-10-22 |
2011-05-12 |
Centre for Digestive Diseases Pty, Ltd. |
Behandlung von nicht-entzündlichen darmerkrankungen
|
|
US5262549A
(en)
*
|
1991-05-30 |
1993-11-16 |
Polaroid Corporation |
Benzpyrylium dyes, and processes for their preparation and use
|
|
US5302751A
(en)
|
1992-01-21 |
1994-04-12 |
Ethyl Corporation |
Profen resolution
|
|
DE69331727D1
(de)
|
1992-06-30 |
2002-04-25 |
Howard K Shapiro |
Verwendung einer kombination bestehend aus einem aminderivat oder aminverwandten derivat der benzoesäure und einem amino-polysaccharide zur herstellung eines medikaments fuer die behandlung von entzündlichen erkrankungen
|
|
US5594151A
(en)
*
|
1994-01-28 |
1997-01-14 |
Prolinx, Inc. |
Phenylboronic acid complexing reagents derived from aminosalicylic acid
|
|
CA2190107A1
(en)
|
1994-05-11 |
1995-11-23 |
Secant Pharma, Llc |
Compositions for treatment of chronic inflammatory diseases
|
|
US5594015A
(en)
|
1994-06-22 |
1997-01-14 |
Regents Of The University Of California |
Thiazolidine derivatives for the treatment of psoriasis
|
|
WO1996030016A2
(en)
|
1995-03-28 |
1996-10-03 |
Janssen Pharmaceutica N.V. |
Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases
|
|
US5939442A
(en)
*
|
1995-06-07 |
1999-08-17 |
The Salk Institute For Biological Studies |
Modulations of peroxisome proliferator activated receptor-γ, and methods for the use thereof
|
|
GB9600464D0
(en)
*
|
1996-01-09 |
1996-03-13 |
Smithkline Beecham Plc |
Novel method
|
|
GB9617001D0
(en)
|
1996-08-13 |
1996-09-25 |
Tillotts Pharma Ag |
Oral composition
|
|
DE19647582A1
(de)
*
|
1996-11-18 |
1998-05-20 |
Hoechst Ag |
Verfahren zur Herstellung von aromatischen Olefinen mittels Katalyse durch Palladaphosphacyclobutane
|
|
WO1998043081A1
(en)
|
1997-03-26 |
1998-10-01 |
Ligand Pharmaceuticals Incorporated |
Treatment of gastrointestinal disease with ppar modulators
|
|
US7098025B1
(en)
*
|
1997-07-25 |
2006-08-29 |
Ligand Pharmaceuticals Incorporated |
Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor
|
|
AU9002798A
(en)
*
|
1997-09-19 |
1999-04-12 |
Ono Pharmaceutical Co. Ltd. |
Fused or nonfused benzene compounds
|
|
FR2773075B1
(fr)
|
1997-12-31 |
2000-05-05 |
Cird Galderma |
Utilisation d'activateurs de ppar-gamma en dermatologie
|
|
US6114382A
(en)
|
1998-11-11 |
2000-09-05 |
Moretti; Itagiba G. |
Methods for treating inflammatory bowel disease
|
|
US6326364B1
(en)
*
|
1999-02-08 |
2001-12-04 |
Cedars-Sinai Medical Center |
Use of 5-aminosalicylates as antimicrobial agents
|
|
FR2791671B1
(fr)
|
1999-04-01 |
2001-05-11 |
Oreal |
Nouveaux composes derives d'esters d'acide benzoique, composition les comprenant et utilisation
|
|
GB9908647D0
(en)
|
1999-04-15 |
1999-06-09 |
Smithkline Beecham Plc |
Novel compounds
|
|
US20040034067A1
(en)
*
|
1999-04-15 |
2004-02-19 |
Macphee Colin Houston |
Novel method of treatment
|
|
GB9914371D0
(en)
|
1999-06-18 |
1999-08-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
TWI262185B
(en)
|
1999-10-01 |
2006-09-21 |
Eisai Co Ltd |
Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
|
|
ATE275127T1
(de)
|
2000-04-19 |
2004-09-15 |
Neurotech Co Ltd |
Verbindungen, zusammensetzungen und verfahren zur vorbeugung der neurodegeneration bei akuten oder chronischen verletzungen des zentralen nervensystems
|
|
DE60135742D1
(de)
*
|
2000-05-29 |
2008-10-23 |
Kyorin Seiyaku Kk |
Substituierte phenylpropionsäure-derivate
|
|
US7049342B2
(en)
|
2000-05-29 |
2006-05-23 |
Kyorin Pharmaceutical Co., Ltd. |
Substituted phenylpropionic acid derivatives
|
|
WO2002018324A2
(en)
|
2000-08-29 |
2002-03-07 |
Nobex Corporation |
Immunoregulatory compounds, derivatives thereof and their use
|
|
AU2002222574A1
(en)
|
2000-12-05 |
2002-06-18 |
Kyorin Pharmaceutical Co. Ltd. |
Substituted carboxylic acid derivatives
|
|
FR2822955B1
(fr)
|
2001-03-27 |
2003-10-03 |
Chru Lille |
Methode de diagnostic de maladies inflammatoires chroniques de l'intestin
|
|
WO2002085123A1
(en)
|
2001-04-18 |
2002-10-31 |
Merck & Co., Inc. |
Ppar-alpha-gamma ligands or agonists for the treatment of inflammation
|
|
CA2354921A1
(en)
|
2001-05-24 |
2002-11-24 |
Yasuo Konishi |
Drug evolution: drug design at hot spots
|
|
US20110105748A1
(en)
*
|
2001-10-16 |
2011-05-05 |
Debnath Bhuniya |
Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds
|
|
GB0127916D0
(en)
|
2001-11-21 |
2002-01-16 |
Rowett Res Inst |
Method
|
|
UA82835C2
(en)
*
|
2001-12-03 |
2008-05-26 |
Reddys Lab Ltd Dr |
?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
|
|
US20030113815A1
(en)
*
|
2001-12-19 |
2003-06-19 |
Pfizer Inc. |
Canine peroxisome proliferator activated receptor gamma
|
|
US20030220374A1
(en)
*
|
2002-01-14 |
2003-11-27 |
Pharmacia Corporation |
Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
|
|
US20040115127A1
(en)
*
|
2002-04-12 |
2004-06-17 |
Wright Samuel D. |
Ppar-alpha-gamma ligands or agonists for the treatment of inflammation
|
|
GB0303609D0
(en)
|
2003-02-17 |
2003-03-19 |
Glaxo Group Ltd |
Novel therapeutic method and compositions
|
|
US20060159648A1
(en)
|
2003-02-17 |
2006-07-20 |
Davis Adrian F |
Novel therapeutic method and compositions for topical administration
|
|
US20060177444A1
(en)
*
|
2003-03-20 |
2006-08-10 |
Tatsuo Horizoe |
Concomitant drug as therapeutic agent for inflammatory bowel disease
|
|
EP1654247B1
(en)
|
2003-07-21 |
2010-01-20 |
Merck Serono SA |
Alkynyl aryl carboxamides
|
|
GB2422782A
(en)
|
2003-10-21 |
2006-08-09 |
Inspire Pharmaceuticals Inc |
Non-nucleotide compositions and method for treating pain
|
|
US20070093476A1
(en)
*
|
2003-10-28 |
2007-04-26 |
Bhunia Debnath |
Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
|
|
JP2007513173A
(ja)
|
2003-12-03 |
2007-05-24 |
スミスクライン・ビーチャム・コーポレイション |
ロシグリタゾンを用いる乾癬の治療
|
|
WO2005072113A2
(en)
|
2004-01-20 |
2005-08-11 |
Harty Richard F |
Compositions and methods of treatment for inflammatory diseases
|
|
WO2005084658A1
(en)
|
2004-03-04 |
2005-09-15 |
Arakis Ltd. |
Derivatives of actarit and their therapeutic use
|
|
US20060286046A1
(en)
|
2005-01-05 |
2006-12-21 |
Haber C Andrew |
Skin care compositions
|
|
US20060270635A1
(en)
*
|
2005-05-27 |
2006-11-30 |
Wallace John L |
Derivatives of 4- or 5-aminosalicylic acid
|
|
ITRM20050389A1
(it)
|
2005-07-22 |
2007-01-23 |
Giuliani Spa |
Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
|
|
ITRM20050390A1
(it)
|
2005-07-22 |
2007-01-23 |
Giuliani Spa |
Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
|
|
DE102005061472A1
(de)
|
2005-12-22 |
2007-07-05 |
Saltigo Gmbh |
Verfahren zur Herstellung von enantiomerenangereicherten 2-Alkoxy-3-phenylpropionsäuren
|
|
WO2007096148A1
(en)
|
2006-02-23 |
2007-08-30 |
Lipid Nutrition B.V. |
Immunoregulation
|
|
US7645801B2
(en)
|
2007-01-29 |
2010-01-12 |
Alaven Pharmaceutical Llc |
Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
|
|
IE20070129A1
(en)
|
2007-02-28 |
2008-12-24 |
Giuliani Int Ltd |
Ppar-gamma agonists stimulate enteric defensin expression
|
|
WO2009025854A1
(en)
|
2007-08-22 |
2009-02-26 |
Burnham Institute For Medical Research |
Smips: small molecule inhibitors of p27 depletion in cancers and other proliferative diseases
|
|
ITMI20072429A1
(it)
|
2007-12-24 |
2009-06-25 |
Giuliani Int Ltd |
Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca
|
|
US8030520B2
(en)
|
2008-03-31 |
2011-10-04 |
Saltigo Gmbh |
Process for preparing organic compounds by a transition metal-catalysed cross-coupling reaction of an aryl-X, heteroaryl-X, cycloalkenyl-X or alkenyl-X compound with an alkyl, alkenyl, cycloalkyl or cycloalkenyl halide
|
|
UA107562C2
(uk)
|
2008-12-05 |
2015-01-26 |
|
Спосіб лікування псоріазу
|
|
SI2805746T1
(sl)
|
2009-02-16 |
2020-10-30 |
Nogra Pharma Limited |
Alkilamido spojine in njihova uporaba
|
|
EP2298321A1
(en)
|
2009-08-26 |
2011-03-23 |
Nordic Pharma |
Novel pharmaceutical compositions for treating IBD
|
|
EP2731605A4
(en)
|
2011-07-15 |
2015-02-25 |
Sla Pharma Ag |
Pharmaceutical compositions for rectal administration
|
|
WO2013064153A1
(en)
|
2011-10-31 |
2013-05-10 |
Claus Selch Larsen |
Prodrugs of non- steroid anti - inflammatory agents (nsaids)
|
|
CA2864059C
(en)
|
2012-02-09 |
2020-04-28 |
Nogra Pharma Limited |
Methods of treating fibrosis
|
|
MX2014012652A
(es)
|
2012-04-18 |
2014-11-25 |
Nogra Pharma Ltd |
Metodo de tratamiento de la intolerancia a la lactosa.
|
|
US9013997B2
(en)
|
2012-06-01 |
2015-04-21 |
Broadcom Corporation |
System for performing distributed data cut-through
|
|
MX2014014657A
(es)
|
2012-06-01 |
2015-08-10 |
Nogra Pharma Ltd |
Heterociclos bicíclicos capaces de modular las respuestas de los linfocitos t, y métodos de uso de los mismos.
|
|
KR20150053974A
(ko)
|
2012-09-13 |
2015-05-19 |
노그라 파마 리미티드 |
모발 성장 억제 방법
|
|
EP2895160B1
(en)
|
2012-09-13 |
2018-05-30 |
Nogra Pharma Limited |
Methods of treating hair related conditions
|
|
WO2016154730A1
(en)
|
2015-04-02 |
2016-10-06 |
University Health Network |
Gut anti-inflammatory agents for regulation of high blood glucose levels
|
|
DK3307262T3
(da)
|
2015-06-15 |
2021-08-09 |
Nmd Pharma As |
Forbindelser til anvendelse ved behandling af neuromuskulære lidelser
|